A postmenopausal patient with tangier disease developing Sjögren's syndrome

Journal of Rheumatology

Volumn 36, Issue 1, 2009, Pages 208-209

  Miyachi, Kiyomitsu ^a,f   Hankins, Raleigh W ^a   Uehara, Yoshinari ^b   Bo, Zhang ^b   Saku, Keijiro ^b   Homma, Yasuhiko ^c   Shigematsu, Hiroshi ^d   Mikoshiba, Katsuhiko ^e  

^a Health Sciences Research Institute Inc

^b FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Sato Clinic   (Japan)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^f Keigu Clinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; CENTROMERE ANTIBODY; ESTROGEN; HIGH DENSITY LIPOPROTEIN; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; LOW DENSITY LIPOPROTEIN;

CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; DISEASE COURSE; ESTROGEN THERAPY; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; LETTER; POSTMENOPAUSE; PRIORITY JOURNAL; SJOEGREN SYNDROME; SKIN MANIFESTATION; SYSTEMIC SCLEROSIS; TANGIER DISEASE;

ADULT; AMINO ACID SEQUENCE; ATP-BINDING CASSETTE TRANSPORTERS; BASE SEQUENCE; FEMALE; HUMANS; MOLECULAR SEQUENCE DATA; POSTMENOPAUSE; SJOGREN'S SYNDROME; TANGIER DISEASE;

EID: 58149496689     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.080417     Document Type: Letter

References (11)

1. Brooks-Wilson A, Marcil M, Clee SM, et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 1999;22:336-45.
2. Miyachi K, Iwai M, Asada K, Saito I, Hankins R, Mikoshiba K. Inositol 1,4,5-trisphosphate receptors are autoantibody target antigens in patients with Sjogren's syndrome and other systemic rheumatic diseases. Mod Rheumatol 2007;17:137-43.
3. Zhang B, Bottcher A, Imaizumi S, Noda K, Schmitz G, Saku K. Relation between charge-based apolipoprotein B-containing lipoprotein subfractions and remnant-like particle cholesterol levels. Atherosclerosis 2007;191:153-61.
4. Miyawaki S, Asanuma H, Nishiyama S, Yoshinaga Y. Clinical and serological heterogeneity in patients with anti-centromere antibodies. J Rheumatol 2005;32:1488-94.
5. Melby MK. Climacteric symptoms among Japanese women and men: comparison of four symptoms checklists. Climacteric 2006;9:298-304.
6. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Committee. Arthritis Rheum 1990;33:160-72.
7. Serfaty LC, Civeira F, Lanzberg A, et al. Homozygous Tangier disease and cardiovascular disease. Atherosclerosis 1994;107:85-96.
8. Uehara Y, Tsuboi Y, Zhang B, et al. POPC/apoA-I discs as a potent lipoprotein modulator in Tangier disease. Atherosclerosis 2008;197:283-9.
9. Singaraja RR, Brunham LR, Visscher H, Kastelein JJP, Hayden MR. The clinical and biochemical impact of variations in the ABCA1 gene. Arterioscler Thromb Vasc Biol 2003;23:1322-32.
10. Miyachi K, Hankins R, Ihara M, et al. A case of limited cutaneous systemic sclerosis developing anti-mitochondrial antibody positive primary biliary cirrhosis after acute myocardial infarction. Clin Rheumatol 2007;26:1571-4.
11. Writing Group for the Women's Health Initiative Investigators. Risk and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002;288:321-33.